Aptevo Therapeutics
APVO
APVO
12 hedge funds and large institutions have $352K invested in Aptevo Therapeutics in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
69% less capital invested
Capital invested by funds: $1.13M → $352K (-$774K)
Holders
12
Holding in Top 10
–
Calls
$8K
Puts
–
Top Buyers
| 1 | +$64.6K | |
| 2 | +$47.4K | |
| 3 | +$25.1K | |
| 4 |
Millennium Management
New York
|
+$18.9K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$5.76K |
Top Sellers
| 1 | -$199K | |
| 2 | -$173K | |
| 3 | -$22.1K | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$16K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$7.82K |